Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · July 07, 2022

Effects of Randomized Treatment With Icosapent Ethyl or Mineral Oil on Atherosclerotic Biomarkers



Additional Info

Disclosure statements are available on the authors' profiles:

Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy
Circulation 2022 Jun 28;[EPub Ahead of Print], PM Ridker, N Rifai, J MacFadyen, RJ Glynn, L Jiao, PG Steg, M Miller, EA Brinton, TA Jacobson, JC Tardif, CM Ballantyne, RP Mason, DL Bhatt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading